|

Medroxyprogesterone acetate + Atorvastatin Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Peking University People's Hospital1

Indications

  • Endometrial Carcinoma Stage I1
  • Atypical Endometrial Hyperplasia1
  • Cancer1

Other1 trial

Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.